Surgical

SofPort® Advanced Optics Aspheric Lens System - Brief Statement

Indications

The Bausch & Lomb SofPort® Advanced Optics Aspheric Lenses are intended to be used for primary implantation for the visual correction of aphakia in patients 60 years of age or older where a cataractous lens has been removed by extracapsular cataract extraction methods. They are intended for placement in the ciliary sulcus or capsular bag. NOTE: Implantation of intraocular lenses should not be performed in patients under 18 years of age.

Warnings

As with any surgical procedure, there is risk involved. Potential complications accompanying cataract or implant surgery may include but are not limited to the following: lens dislocation, manifestations of inflammation, corneal endothelial damage, infection (endophthalmitis), retinal detachment, vitritis, cystoid macular edema, corneal edema, pupillary or cyclitic membrane, iris prolapse, hypopyon, and transient or persistent glaucoma.

The safety and effectiveness of this lens, if placed in the anterior chamber, has not been established. Implantation of posterior chamber lenses in the anterior chamber has been shown in some cases to be unsafe. Such implantation should take place only under an investigational protocol approved by the FDA.

Pupillary block may be prevented by one or more iridectomies performed at the time of implantation.

The long-term effects of intraocular lens implantation have not been determined. Therefore, physicians should continue to monitor implant patients postoperatively on a regular basis.

Undesirable optical effects such as glare, halos, etc. have been reported by some patients after intraocular lens implantation. These phenomena are not completely understood but are thought to be related to positioning holes and edge effects.

The effectiveness of these lenses in reducing the incidence of retinal disorders has not been established.

The safety of intraocular lens implantation has not been substantiated in patients with pre-existing ocular conditions (e.g., chronic drug miosis, glaucoma, amblyopia, diabetic retinopathy, previous corneal transplant, history of retinal detachment, iritis, etc.). Physicians considering lens implants in such patients should explore the use of alternative methods of aphakic correction and consider lens implantation only if alternatives are deemed unsatisfactory to meet the needs of the patient.

Patients with preoperative problems such as corneal endothelial disease, abnormal cornea, macular degeneration, glaucoma, and chronic drug miosis may not achieve the visual acuity of patients without such problems. The physicians must determine the benefits to be derived from lens implantation when such conditions exist.

Patients who experience surgical complications associated with the cataract extraction procedure (posterior capsule rupture, detached Descemet's membrane, anterior chamber bleeding, iris damage, or vitreous bulge or loss) may experience poorer visual acuity. Medical judgment must be exercised to determine if a lens should be implanted when surgical problems occur.

Patients who experience postoperative complications, particularly macular edema, may have a slightly higher risk of experiencing poorer visual outcome than patients without sight-threatening complications.

Precautions

Do not resterilize these lenses by any method. Do not store lenses at temperatures over 45°C. Use only sterile intraocular irrigating solutions, e.g., balanced salt or normal saline solution, to rinse and/or soak lenses. Patients with any of the following conditions may not be suitable candidates for an intraocular lens because the lens may exacerbate an existing condition, or may interfere with diagnosis or treatment of a condition, or may pose an unreasonable risk to the patient's eyesight:

  • Congenital bilateral cataracts
  • Recurrent anterior or posterior segment inflammation of unknown etiolog
  • Patients in whom the intraocular lens may interfere with the ability to observe, diagnose, or treat posterior segment diseases
  • Surgical difficulties at the time of cataract extraction which might increase the potential for complications; e.g., persistent bleeding, significant iris damage, uncontrollable positive pressure or significant vitreous prolapse or loss
  • Patients with only one eye with potentially good vision
  • Medically uncontrollable glaucoma
  • Corneal endothelial dystrophy
  • Proliferative diabetic retinopathy

It is recommended that each patient receive information regarding intraocular lenses in a manner that is suitable to the patient. This information should be provided prior to the decision to implant an intraocular lens. Postoperative information should also be provided by the physician.

 

Adverse Events

The following adverse reactions have been reported: Hyphema, macular edema, secondary glaucoma, cyclitic membrane, vitritis, retinal detachment, lens dislocation, hypopyon, intraocular infection, acute corneal decompensation, and secondary surgical intervention.